Stock listing
gettex:M3Z COLTENE Holding AG Aktie
German listing (gettex) of COLTENE Holding AG · home listing SIX Swiss:CLTN
Follow COLTENE Holding AG into a list and get an email when it puts out news.
Home listing price · SIX:CLTN
47.30 CHF -0.50 (-1.0%)
Close on Nov 20, 2026 · This listing has no price on 6ix; the price shown is the home listing's, SIX:CLTN
- Day range
- 47.30 – 48.40 CHFNov 20, 2026
- Volume
- 1,058 sharesNov 20, 2026
- Market cap
- 282.6M CHFAt the close on Nov 20, 2026 · price × 5.98M shares outstanding
- 52-week range
- 44.25 – 59.00 CHFLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- 86,084 CHFMedian day 1,477 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| SIX Swiss:CLTN · Home | 47.30 CHF | -0.50 (-1.0%) | 1,058 | 47.30 | 48.40 | 47.30 | 47.80 | Close on Nov 20, 2026 |
| LSE:0QP7 | 47.10 CHF | -0.975 (-2.0%) | 405 | 47.30 | 47.30 | 47.10 | 48.08 | Close on Nov 19, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · SIX:CLTN · CHF, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| 47.30 | -0.50 | -1.0% | 47.30 | 48.40 | 47.30 | 1,058 | |
| 47.80 | -0.45 | -0.9% | 48.45 | 48.45 | 47.80 | 1,887 | |
| 48.25 | -0.10 | -0.2% | 48.15 | 48.25 | 47.80 | 1,329 | |
| 48.35 | +0.40 | +0.8% | 48.15 | 48.35 | 48.00 | 964 | |
| 47.95 | -0.50 | -1.0% | 48.25 | 48.65 | 47.90 | 1,446 | |
| 48.45 | +0.60 | +1.3% | 48.05 | 48.65 | 47.85 | 1,240 | |
| 47.85 | -0.15 | -0.3% | 48.00 | 48.30 | 47.85 | 1,146 | |
| 48.00 | -0.65 | -1.3% | 48.85 | 49.50 | 48.00 | 2,367 | |
| 48.65 | -0.65 | -1.3% | 49.10 | 49.70 | 48.55 | 2,142 | |
| 49.30 | +0.30 | +0.6% | 48.80 | 49.30 | 48.65 | 1,478 | |
| 49.00 | +0.60 | +1.2% | 48.60 | 49.05 | 48.40 | 1,730 | |
| 48.40 | +0.45 | +0.9% | 47.75 | 48.60 | 47.55 | 2,058 | |
| 47.95 | -1.05 | -2.1% | 48.90 | 49.20 | 47.20 | 1,590 | |
| 49.00 | -0.30 | -0.6% | 49.10 | 49.50 | 48.50 | 1,182 | |
| 49.30 | +0.70 | +1.4% | 48.80 | 49.45 | 48.70 | 1,235 | |
| 48.60 | +0.40 | +0.8% | 48.40 | 49.35 | 48.40 | 1,791 | |
| 48.20 | -0.50 | -1.0% | 48.50 | 49.45 | 48.20 | 1,992 | |
| 48.70 | +0.70 | +1.5% | 48.20 | 48.90 | 48.20 | 2,630 | |
| 48.00 | -0.20 | -0.4% | 48.00 | 48.80 | 47.40 | 1,449 | |
| 48.20 | -0.80 | -1.6% | 48.80 | 48.85 | 47.60 | 1,141 | |
| 49.00 | +0.25 | +0.5% | 48.55 | 49.00 | 48.55 | 2,417 | |
| 48.75 | +0.25 | +0.5% | 48.30 | 48.75 | 47.95 | 1,052 | |
| 48.50 | +0.50 | +1.0% | 48.00 | 48.50 | 47.80 | 1,172 | |
| 48.00 | +0.80 | +1.7% | 46.95 | 48.00 | 46.95 | 1,090 | |
| 47.20 | +0.95 | +2.1% | 46.45 | 47.30 | 46.45 | 1,146 | |
| 46.25 | +0.10 | +0.2% | 45.95 | 46.60 | 45.95 | 2,036 | |
| 46.15 | +0.25 | +0.5% | 45.50 | 46.15 | 45.45 | 1,166 | |
| 45.90 | -0.40 | -0.9% | 45.95 | 46.30 | 45.80 | 1,612 | |
| 46.30 | -0.50 | -1.1% | 46.60 | 46.90 | 45.90 | 1,427 | |
| 46.80 | -0.60 | -1.3% | 47.70 | 47.70 | 46.40 | 878 | |
| 47.40 | +0.30 | +0.6% | 46.90 | 47.75 | 46.45 | 1,399 | |
| 47.10 | +0.85 | +1.8% | 46.05 | 47.10 | 45.85 | 1,267 | |
| 46.25 | +0.75 | +1.6% | 45.50 | 46.25 | 45.50 | 648 | |
| 45.50 | -1.10 | -2.4% | 46.65 | 46.80 | 45.50 | 1,127 | |
| 46.60 | +0.60 | +1.3% | 46.00 | 46.65 | 45.55 | 1,438 | |
| 46.00 | -0.10 | -0.2% | 46.10 | 47.40 | 46.00 | 2,660 | |
| 46.10 | -0.90 | -1.9% | 46.80 | 46.90 | 46.00 | 1,618 | |
| 47.00 | +1.40 | +3.1% | 45.80 | 47.00 | 45.80 | 491 | |
| 45.60 | -0.95 | -2.0% | 46.35 | 46.45 | 45.60 | 417 | |
| 46.55 | +0.60 | +1.3% | 45.75 | 47.00 | 45.40 | 1,939 | |
| 45.95 | +0.15 | +0.3% | 45.80 | 46.20 | 45.50 | 1,269 | |
| 45.80 | -0.20 | -0.4% | 45.80 | 46.20 | 45.80 | 1,054 | |
| 46.00 | +1.00 | +2.2% | 45.00 | 46.65 | 45.00 | 2,159 | |
| 45.00 | -2.30 | -4.9% | 47.50 | 47.50 | 45.00 | 3,575 | |
| 47.30 | +1.05 | +2.3% | 46.05 | 47.30 | 46.05 | 3,662 | |
| 46.25 | +0.25 | +0.5% | 45.80 | 46.40 | 45.70 | 980 | |
| 46.00 | +0.60 | +1.3% | 45.60 | 46.40 | 45.50 | 2,491 | |
| 45.40 | -0.25 | -0.5% | 45.30 | 45.50 | 45.10 | 1,679 | |
| 45.65 | -0.15 | -0.3% | 45.20 | 45.80 | 45.10 | 2,283 | |
| 45.80 | -0.25 | -0.5% | 46.25 | 46.40 | 45.55 | 1,475 | |
| 46.05 | -0.85 | -1.8% | 47.10 | 47.25 | 46.05 | 4,301 | |
| 46.90 | 0.00 | 0.0% | 46.75 | 46.90 | 46.50 | 441 | |
| 46.90 | +0.30 | +0.6% | 46.80 | 47.35 | 46.80 | 2,470 | |
| 46.60 | -0.20 | -0.4% | 47.10 | 47.10 | 46.30 | 4,204 | |
| 46.80 | -0.95 | -2.0% | 48.05 | 48.45 | 46.80 | 2,868 | |
| 47.75 | -0.25 | -0.5% | 47.80 | 48.15 | 47.45 | 2,727 | |
| 48.00 | +0.20 | +0.4% | 47.45 | 48.00 | 47.25 | 2,208 | |
| 47.80 | +0.70 | +1.5% | 47.30 | 47.90 | 47.30 | 1,215 | |
| 47.10 | -1.45 | -3.0% | 48.35 | 48.75 | 47.10 | 6,545 | |
| 48.55 | -0.20 | -0.4% | 48.75 | 49.50 | 48.55 | 4,364 | |
| 48.75 | -0.45 | -0.9% | 48.90 | 49.00 | 48.65 | 1,757 | |
| 49.20 | +1.85 | +3.9% | 47.15 | 49.20 | 47.15 | 2,143 | |
| 47.35 | -0.15 | -0.3% | 47.70 | 48.00 | 47.35 | 1,704 | |
| 47.50 | -0.30 | -0.6% | 48.50 | 48.50 | 47.50 | 1,331 | |
| 47.80 | -1.20 | -2.4% | 48.75 | 48.85 | 47.55 | 1,293 | |
| 49.00 | +1.35 | +2.8% | 47.85 | 49.00 | 47.70 | 1,041 |
- Ticker
- gettex:M3Z
- Asset type
- Stock
- Sector
- Health care
- Industry
- Medical devices & supplies
- Exchange
- gettex
- Currency
- EUR
What changed lately
Latest news release · Mar 6, 2026
COLTENE publishes results for the financial year 2025
Latest deck · Mar 6, 2026
FY2025 Earnings Presentation
Earnings · 27 slides
Latest news
COLTENE publishes results for the financial year 2025
Mar 6, 2026
Closed 50.90 (-6.9%) on Mar 6, 2026
COLTENE Holding AG on 6ix
- Sector
- Health care
- Industry
- Medical devices & supplies
- News releases
- 1 in the last 12 months · 15 in all · newest Mar 6, 2026 · oldest 2023
- Decks
- 34 decks · latest Mar 6, 2026
Where COLTENE Holding AG is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| SIX Swiss:CLTN · Home listing | SIX Swiss | Switzerland | CHF |
| Lang & Schwarz:A0J3ED | Lang & Schwarz | Germany | EUR |
| LS Exchange:A0J3ED | LS Exchange | Germany | EUR |
| BX Swiss:M3Z | BX Swiss | Switzerland | CHF |
| gettex:M3Z · This page | gettex | Germany | EUR |
| LSE:0QP7 | LSE | United Kingdom | CHF |
| Frankfurt:M3Z | Frankfurt | Germany | EUR |
| Aquis:CLTNZ | Aquis | United Kingdom | CHF |
| Dusseldorf:M3Z | Dusseldorf | Germany | EUR |
| Munich:M3Z | Munich | Germany | EUR |
| Stuttgart:M3Z | Stuttgart | Germany | EUR |
| Turquoise:CLTNZ | Turquoise | United Kingdom | CHF |
| OTC:CLHLF | OTC | United States | USD |
Valuation
P/E 18.9× against a median of 33.6×: 3rd lowest of 9 Medical devices & supplies companies shown. Statements: Year to Dec 31, 2025 · balance Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- 316.0M CHF
- P/E
- 18.9×
- EV/sales
- 1.3×
- EV/EBITDA
- 11.4×
- Price/book
- 3.0×
- Gross margin
- 25.6%
- Operating margin
- 8.5%
- Net margin
- 6.2%
- Debt to equity
- 0.6×
- Beta
- No index for this market yet
Medical devices & supplies: the 10 companies nearest in size, of 448 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| COLTENE Holding AG · SIX:CLTN | US$336.6M | US$376.3M | 18.9× | 1.3× | 11.4× | 3.0× | 6.2% | 0.6× | n/a |
| BrainsWay Ltd · TASE:BWAY | US$356.2M | US$299.1M | 35.0× | 4.3× | 26.8× | 4.3× | 14.6% | 0.1× | n/a |
| Star Sports Medicine Co., Ltd Class H · HKEX:1609 | US$347.2M | US$183.4M | 16.9× | 3.0× | 6.8× | 1.8× | 34.0% | 0.0× | n/a |
| Embecta Corp. · NASDAQ:EMBC | US$341.1M | US$1.58B | 3.9× | 1.6× | n/a | n/a | 8.6% | n/a | 0.74 |
| Jiangsu Canopus Wisdom Medical Technology Co., Ltd. Class A · SZSE:301290 | US$330.8M | US$220.5M | 29.6× | 3.4× | n/a | 1.0× | 17.2% | 0.1× | n/a |
| ACRO Biomedical Co., Ltd. · TPEX:6748 | US$327.3M | US$299.5M | n/a | 258× | n/a | 10.1× | −216.1% | 0.0× | n/a |
| Medcaptain Medical Technology Co. Ltd. Class H · HKEX:2041 | US$325.9M | US$288.8M | 44.4× | 1.2× | 9.7× | 1.1× | 3.0% | 0.1× | n/a |
| Yantai Zhenghai Bio-Tech Co. Ltd. Class A · SZSE:300653 | US$325.8M | US$231.2M | 34.2× | 4.8× | n/a | 2.4× | 19.9% | 0.0× | n/a |
| CapsoVision, Inc. · NASDAQ:CV | US$325.1M | US$304.1M | n/a | 21.9× | n/a | 12.3× | −210.1% | 0.0× | 0.88 |
| NIOX Group PLC · LSE:NIOX | US$318.1M | US$297.0M | 34.7× | 4.7× | 15.3× | 3.7× | 14.4% | 0.0× | n/a |
| Nanjing Medlander Medical Technology Co. Ltd. Class A · SSE:688273 | US$315.5M | US$208.7M | 33.0× | 3.6× | n/a | 1.5× | 16.6% | 0.0× | n/a |
| Median of the others | US$326.6M | US$292.9M | 33.6× | 4.0× | 12.5× | 2.4× | 14.5% | 0.0× | 0.81 |
Forecasts
Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.
- Price target
- 55.00 CHF · Analysts' mean
- EPS, year to Dec 2026
- 2.46 · 2 analysts
- Revenue, year to Dec 2026
- 237.1M · 2 analysts
Team and board
Officers
| Officer | Role |
|---|---|
| Dominik Arnold | Chief Executive Officer (CEO) |
| Markus Abderhalden | Chief Financial Officer (CFO) |
| Gregor Picard | Chief Operating Officer (COO) |
| Di Hu | Vice President Sales & Marketing Communication EU&ROW (CSO) |
| Brandon Arsenault | Chief Commercial Officer (CCO) |
| Patrick Bayer | Chief Marketing Officer (CMO) |
Board
| Director | Role |
|---|---|
| Matthias Altendorf | Chairman, Board of Directors |
| Allison Zwingenberger | Board of Directors |
| Astrid Waser | Board of Directors |
| Daniel Bühler | Board of Directors |
| Edgar Schönbächler | Board of Directors |
| Jürgen Rauch | Board of Directors |
| Martin Schaufelberger | Board of Directors |
Events
- Next results
- Mar 5, 2027 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q2 2026 | Jun 30, 2026 | +2.0% |
| Q4 2025 | Dec 31, 2025 | +2.4% |
| Q2 2025 | Jul 25, 2025 · After close | −4.0% |
| Q4 2024 | Mar 7, 2025 | +2.3% |
| Quarter to Sep 30, 2024 | Nov 18, 2024 | +1.2% |
| Q2 2024 | Aug 8, 2024 | +8.7% |
| Quarter to Mar 31, 2024 | May 29, 2024 | +1.6% |
| Q4 2023 | Mar 8, 2024 | +5.4% |
| Quarter to Sep 30, 2023 | Nov 1, 2023 | +3.0% |
| Q2 2023 | Aug 4, 2023 · After close | −2.9% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2023 | May 31, 2023 | −0.6% |
| Q4 2022 | Mar 3, 2023 · Before open | +0.6% |
| Q3 2022 | Nov 2, 2022 | −1.5% |
| Q2 2022 | Aug 5, 2022 · Before open | −4.3% |
| Q1 2022 | Jun 1, 2022 | −0.5% |
| Q4 2021 | Mar 4, 2022 · Before open | −4.5% |
| Q3 2021 | Nov 3, 2021 | −4.6% |
| Q2 2021 | Aug 6, 2021 | +4.4% |
| Q1 2021 | Jun 2, 2021 | +0.5% |
| Q4 2020 | Mar 5, 2021 | +4.0% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| FY2025 Earnings Presentation | Earnings | 27 slides | Mar 6, 2026 |
| H1 2023 Earnings Presentation | Earnings | 20 slides | Aug 4, 2023 |
| Investor Presentation (July 2023) | Investor deck | 20 slides | July 2023 |
| FY2021 Earnings Presentation | Earnings | 32 slides | Mar 4, 2022 |
| H1 2021 Earnings Presentation | Earnings | 28 slides | Aug 6, 2021 |
| FY2020 Earnings Presentation | Earnings | 36 slides | Mar 5, 2021 |
| Investor Presentation (February 2021) | Investor deck | 68 slides | February 2021 |
| Investora 2020 | Conference | 23 slides | Sep 23, 2020 |
| H1 2020 Earnings Presentation | Earnings | 28 slides | Aug 7, 2020 |
| FY2019 Earnings Presentation | Earnings | 34 slides | Mar 5, 2020 |
All 34 decks
Financials
Annual, in CHF
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 240.0M | 250.2M | 242.7M | 267.1M | 279.2M | 248.4M | 273.8M | 204.0M | 168.0M | 160.7M |
| Cost of revenue | 178.5M | 93.2M | 183.1M | 98.7M | 102.1M | 96.9M | 95.7M | 63.3M | 47.9M | 45.6M |
| Gross profit | 61.5M | 157.0M | 59.7M | 168.4M | 177.1M | 160.5M | 178.2M | 140.7M | 120.1M | 115.1M |
| Research and development | 8.34M | 9.88M | 8.57M | 9.05M | 9.46M | 10.9M | 8.15M | 5.29M | 4.70M | |
| Selling, general and administrative | 24.6M | 24.2M | 23.0M | 3.71M | 5.43M | 3.78M | 5.18M | 5.85M | 2.88M | 3.77M |
| Operating income | 20.5M | 26.8M | 19.6M | 34.9M | 43.8M | 23.3M | 32.0M | 23.7M | 25.5M | 23.3M |
| Depreciation and amortization | 7.22M | 6.90M | 6.85M | 6.71M | 6.44M | 6.03M | 6.10M | 5.56M | 5.71M | 5.61M |
| EBITDA | 27.7M | 33.7M | 26.5M | 41.6M | 50.2M | 29.3M | 38.1M | 29.2M | 31.2M | 28.9M |
| Interest expense | 511.0K | 854.0K | 837.0K | 232.0K | 415.0K | 795.0K | 781.0K | 435.0K | 302.0K | 343.0K |
| Income before tax | 18.4M | 26.5M | 16.1M | 32.9M | 41.2M | 18.0M | 28.1M | 21.4M | 24.5M | 23.4M |
| Income tax | 3.50M | 6.01M | 4.17M | 6.94M | 9.49M | 9.80M | 8.11M | 6.53M | 5.45M | 6.18M |
| Net income | 14.9M | 20.5M | 11.9M | 26.0M | 31.7M | 8.23M | 20.0M | 14.9M | 19.1M | 17.3M |
| Earnings per share, basic | 2.50 | 3.43 | 2.00 | 4.35 | 5.31 | 1.38 | 3.35 | 3.16 | 4.52 | 4.10 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 20.7M | 21.9M | 18.4M | 24.2M | 25.7M | 38.5M | 23.0M | 20.9M | 22.0M | 21.6M |
| Short-term investments | 85.0K | 67.0K | 60.0K | 64.0K | 297.0K | 355.0K | 485.0K | 414.0K | ||
| Receivables | 47.0M | 40.5M | 35.4M | 39.2M | 39.8M | 40.7M | 49.5M | 52.5M | 39.6M | 35.4M |
| Inventory | 57.5M | 58.7M | 58.9M | 65.7M | 63.7M | 52.0M | 58.3M | 55.6M | 31.6M | 30.8M |
| Current assets | 126.9M | 126.2M | 118.1M | 133.1M | 131.0M | 135.6M | 138.3M | 140.9M | 94.1M | 88.4M |
| Property, plant and equipment | 43.7M | 48.1M | 47.8M | 48.6M | 49.2M | 47.2M | 47.5M | 42.5M | 28.4M | 30.0M |
| Goodwill | 1.73M | 974.0K | 172.8M | 39.8M | 38.1M | |||||
| Total assets | 184.8M | 186.9M | 175.4M | 190.6M | 186.7M | 187.6M | 189.8M | 420.2M | 167.3M | 160.4M |
| Accounts payable | 11.1M | 11.5M | 11.1M | 5.00M | 12.1M | 7.69M | 11.9M | 12.4M | 6.51M | 4.70M |
| Current liabilities | 77.5M | 72.9M | 73.6M | 73.1M | 74.4M | 91.0M | 93.2M | 90.3M | 31.4M | 31.5M |
| Long-term debt | 0 | 0 | 4.00K | 93.0K | 153.0K | 4.07M | ||||
| Total debt | 47.0M | 40.0M | 45.0M | 47.1M | 42.9M | 60.3M | 59.8M | 50.1M | 8.28M | 12.9M |
| Total liabilities | 84.3M | 78.2M | 78.5M | 78.4M | 79.3M | 97.4M | 98.6M | 124.1M | 45.6M | 48.1M |
| Shareholders' equity | 100.5M | 108.8M | 96.9M | 112.2M | 107.4M | 90.2M | 91.2M | 296.2M | 121.7M | 112.3M |
| Shares outstanding | 5.97M | 5.98M | 5.98M | 5.97M | 5.97M | 5.98M | 5.97M | 4.71M | 4.22M | 4.22M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | 13.8M | 28.6M | 26.0M | 23.4M | 32.5M | 34.8M | 23.8M | 24.6M | 21.9M | 22.7M |
| Capital spending | -4.60M | -5.75M | -8.68M | -8.32M | -9.90M | -9.47M | -13.3M | -13.0M | -4.40M | -5.74M |
| Free cash flow | 9.17M | 22.8M | 17.3M | 15.1M | 22.6M | 25.3M | 10.5M | 11.7M | 17.5M | 16.9M |
| Cash from investing | -5.66M | -8.53M | -8.56M | -8.20M | -9.79M | -10.5M | -13.1M | -115.4M | -5.87M | -5.61M |
| Cash from financing | -8.18M | -17.1M | -21.9M | -15.9M | -35.8M | -8.08M | -8.35M | 90.0M | -15.7M | -10.1M |
| Dividends paid | -14.9M | -11.9M | -19.7M | -19.7M | -17.9M | -8.96M | -17.9M | -12.7M | -11.4M | -9.28M |
| Share buybacks | -253.0K | -123.0K | -153.0K | -353.0K | -279.0K | -220.0K | -9.27M | -585.0K | 330.0K | 96.0K |
| Change in cash | -1.20M | 3.50M | -5.86M | -1.51M | -12.7M | 15.5M | 2.06M | -1.14M | 470.0K | 6.93M |
Cap table
Built by 6ix from COLTENE Holding AG’s releases
- Common shares
- 5,975,361
- Fully diluted
- 5,975,361
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 5,975,361 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 5,975,361 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Allison Zwingenberger | Board of Directors · Since at least Nov 6, 2026 |
| Astrid Waser | Board of Directors · Since at least Nov 6, 2026 |
| Brandon Arsenault | Chief Commercial Officer (CCO) · Since at least Nov 6, 2026 |
| Daniel Bühler | Board of Directors · Since at least Apr 23, 2025 |
| Di Hu | Vice President Sales & Marketing Communication EU&ROW (CSO) · Since at least Mar 7, 2025 |
| Dominik Arnold | Chief Executive Officer (CEO) · Since at least Jul 25, 2025 |
| Edgar Schönbächler | Board of Directors · Since at least Nov 6, 2026 |
| Gregor Picard | Chief Operating Officer (COO) · Since at least Nov 6, 2026 |
| Jürgen Rauch | Board of Directors · Since at least Apr 23, 2025 |
| Markus Abderhalden | Chief Financial Officer (CFO) · Since at least Mar 6, 2026 |
All 13 people
| Person | Seat |
|---|---|
| Martin Schaufelberger | Board of Directors · Since at least Apr 23, 2025 |
| Matthias Altendorf | Chairman, Board of Directors · Since at least Apr 23, 2025 |
| Patrick Bayer | Chief Marketing Officer (CMO) · Since at least Nov 6, 2026 |
Log in to ask 6ix AI your own questions about COLTENE Holding AG.